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In 2016, an emaciated black rhinoceros (Diceros bicor-
nis) was found in Kruger National Park, South Africa. 
An interferon-γ response was detected against mycobacte-
rial antigens, and lung tissue was positive for Mycobacte-
rium bovis. This case highlights the risk that tuberculosis 
presents to rhinoceros in M. bovis–endemic areas.  
Black rhinoceros (Diceros bicornis) are under severe threat from poaching and habitat loss. This species 
has been designated as critically endangered by the In-
ternational Union for Conservation of Nature Red List 
(1). An estimated population of 5,000–5,445 animals are 
found in southern and eastern Africa, with just over 1,200 
of those in South Africa (2). In Kruger National Park 
(KNP) in South Africa, the black rhinoceros population 
size is estimated at 400. KNP is considered an endemic 
area for Mycobacterium bovis, with cases reported in at 
least 12 wildlife species, including African buffalo, lion, 
kudu, and warthog (3).
Sporadic cases of tuberculosis (TB) caused by M. tu-
berculosis or M. bovis have been reported in black rhinoc-
eros housed in zoos or under semi-intensive management 
(4). Although M. bovis is present in livestock and other 
wildlife species in countries in Africa where rhinoceros 
populations are currently present, no cases of TB have been 
reported in free-ranging black rhinoceros.
On June 17, 2016, rangers in KNP reported a weak, 
emaciated, adult female black rhinoceros that had been 
stationary for 36 hours in the southern area of the park 
(25°7′16′′S, 31°55′2′′E). The discovery of this animal 
might have resulted from increased surveillance related 
to poaching. When veterinary staff arrived, the rhinoceros 
was unresponsive and recumbent and lifted its head only 
when darted. External injuries were not obvious. Because 
of its poor prognosis, the animal was euthanized after 
being immobilized. Postmortem evaluation revealed an 
emaciated animal (body condition score 1 out of 5, http://
www.daff.qld.gov.au/__data/assets/pdf_file/0015/53520/
Animal-HD-Investigation-Condition-scores.pdf) with a 
subjectively heavy ectoparasite load. The subcutaneous 
and internal fat stores were reduced, consistent with the 
poor general body condition. Although teeth were worn, 
they appeared sufficient for mastication, and well-chewed 
ingesta was found in the gastrointestinal system. No 
grossly abnormal changes were found in the organs exam-
ined, except for the lungs and lymph nodes. On palpation 
of the lungs, numerous firm, focal, and irregular masses, 
1–6 cm in diameter, were present in the right and left 
dorso-cranial two thirds of the lung lobes, with symmet-
ric lesion distribution. On cut section, most lesions had a 
fibrous capsule and contained creamy necro-caseous ma-
terial. Impression smears from the lung lesions revealed 
numerous acid-fast bacilli.
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The heparinized whole blood samples that were col-
lected before the animal was euthanized were incubated 
in Nil and TB Antigen tubes of the QuantiFERON TB 
Gold In-Tube system (QIAGEN, Venlo, Netherlands) and 
with pokeweed mitogen (Sigma-Aldrich Pty., Ltd., Johan-
nesburg, South Africa) as a positive control. After 24 h, 
plasma was harvested and interferon-γ (IFN-γ) was mea-
sured in these samples by using a bovine IFN-γ ELISA 
(Mabtech AB, Nacka Strand, Sweden) as previously de-
scribed for African buffaloes (5). IFN-γ concentrations 
measured in the sample from the Nil tube, pokeweed 
mitogen tube, and TB Antigen tube were 4 pg/mL, 753 
pg/mL, and 175 pg/mL, respectively. The TB antigen-
specific release of IFN-γ was consistent with immuno-
logic sensitization to M. bovis or M. tuberculosis (5). We 
detected no antibodies to the M. bovis antigens MPB83 
or ESAT6/CFP10 complex in serum samples tested with 
the Dual Path Platform VetTB assay (Chembio Diagnos-
tic Systems, Inc., Medford, NY, USA) (6). PCR analyses 
confirmed M. bovis infection, both directly from the lung 
tissue and indirectly from mycobacteria culturing of lung 
tissue samples, as previously described (7,8).
Because black rhinoceros have been shown to be sus-
ceptible to TB, it is not unexpected to diagnose bovine TB 
in a free-ranging rhinoceros in an area with a high preva-
lence of TB in other wildlife species (4). Risk factors such 
as environmental load of mycobacteria, presence of con-
current disease, and other stressors (including malnutrition 
associated with drought) might result in progression of M. 
bovis infection. Although the source of infection for the 
animal we describe is unknown, no known exposure to hu-
mans or livestock has occurred. It is possible that interac-
tion with other infected wildlife, including African buffalo, 
which are considered maintenance hosts of bovine TB, or 
environmental contamination at shared water holes and 
feeding sites might have resulted in pathogen contact (8,9). 
Occurrence of M. bovis infection in a free-ranging 
black rhinoceros in KNP might have substantial conse-
quences for conservation programs. The risk for disease 
transmission between isolated, small populations of criti-
cally endangered species could hinder future transloca-
tion of these animals. Further risk assessments are needed 
to investigate the importance of this finding.
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